Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1129f43c9046b74a8d04b2a28015395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4522f24d9c8e00d5ed8045184daccf1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a16c6e36d2c8b096097f7dc379b5f5e8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd24718ca8faabca1190ce5cc7ffc61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d750f404d3fdb4bd4723d62874944f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d74a966c7daca8466e3da68bcf773eb8 |
publicationDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006155125-A1 |
titleOfInvention |
Synthetic process |
abstract |
The present invention provides a process for preparing compounds of formula (IV) n nor a pharmaceutically acceptable salt thereof. The compounds prepared by the process of the invention inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217369-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7358256-B2 |
priorityDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |